CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company
ENDONOVO THERAPEUTICS, INC.
Sign in to watch- Ticker
- ENDV
- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452552528
- Phone
- (800) 489-4774
- Business address
- 6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
- Former names
- Hanover Portfolio Acquisitions, Inc.
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 4 Open-market buy CEO bought 400 shares at an average $0.10 ($41)
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- RW WD Other RW WD
- POS AM Other Post-effective Amendment for Registration Statement
- RW Other RW
- 8-K Event Material agreement
- 8-K Event Other events
- NT 10-Q Other NT 10-Q
- 10-K Report Annual Report
- 8-K Event Other events
- NT 10-K Other NT 10-K
- 8-K Event Other events
Page 3 of 26 · 502 filings